Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Assets Average (2021 - 2025)

Bioventus (BVS) has disclosed Assets Average for 5 consecutive years, with $692.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 7.5% year-over-year to $692.6 million, compared with a TTM value of $692.6 million through Dec 2025, down 7.5%, and an annual FY2025 reading of $705.8 million, down 8.28% over the prior year.
  • Assets Average was $692.6 million for Q4 2025 at Bioventus, down from $704.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $1.4 billion in Q4 2022 and bottomed at $568.8 million in Q2 2021.
  • Average Assets Average over 5 years is $893.0 million, with a median of $748.7 million recorded in 2024.
  • The sharpest move saw Assets Average soared 113.0% in 2022, then decreased 28.98% in 2024.
  • Year by year, Assets Average stood at $940.3 million in 2021, then skyrocketed by 47.33% to $1.4 billion in 2022, then decreased by 18.43% to $1.1 billion in 2023, then plummeted by 33.74% to $748.7 million in 2024, then fell by 7.5% to $692.6 million in 2025.
  • Business Quant data shows Assets Average for BVS at $692.6 million in Q4 2025, $704.2 million in Q3 2025, and $699.1 million in Q2 2025.